Brendan L Raizenne

6PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersMolecular targetsPodiatryRegenerative medicine (incl. stem cells)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 17, 2026
Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky

|Jan 11, 2025
Cost-Effectiveness of PARP Inhibitors for Patients with BRCA1/2-Positive Metastatic Castration-Resistant Prostate Cancer-The Canadian Perspective.

Ivan Yanev, Armen G Aprikian, Brendan L Raizenne

|Feb 09, 2024
The impact of kidney stone disease on quality of life in high-risk stone formers.

Anis Assad, Brendan L Raizenne, Mohammed El Mehdi El Yamani

|Dec 03, 2022
Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study.

Brendan L Raizenne, Xinyan Zheng, Kussil Oumedjbeur

|Aug 30, 2022
Functional and surgical outcomes of Aquablation in elderly men.

Brendan L Raizenne, David Bouhadana, Kevin C Zorn

Pageof 1

Frequent Collaborators

2 joint publications

John P Sfakianos

2 joint publications

Sima Porten

2 joint publications

Anobel Y Odisho

2 joint publications

Reuben Ben-David